ReadyRx
ReadyRx is a US-based direct-to-consumer telehealth platform operated by Executive Medical, LLC that delivers subscription compounded prescription therapies for longevity, weight loss, hormone optimization, and metabolic health to individual adult consumers.
- Company typePrivate
- Founded-
- HeadquartersLos Angeles, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What ReadyRx does
ReadyRx is a U.S.-based direct-to-consumer telehealth platform operated by Executive Medical, LLC that delivers personalized compounded prescription therapies for longevity, weight loss, and metabolic health to individual adult consumers in the United States. The platform is organized around a three-entity operational structure that separates technology infrastructure, clinical decision-making by independent licensed providers, and medication dispensing by partner FDA-registered U.S.-based compounding pharmacies, which allows ReadyRx to scale physician coverage and pharmacy fulfillment without directly employing clinicians or manufacturing in-house.
The product portfolio spans 12 SKUs across three categories: metabolic health (Semaglutide injection, Tirzepatide, Ozempic®, Zepbound®, and Metformin); hormone health (Sermorelin injection and Sermorelin ODT orally dissolving tablet); and energy and recovery (NAD+ injection, NAD+ nasal spray, Glutathione injection, Glutathione nasal spray, and MIC+B12 lipotropic injection). The platform supports needle-free delivery formats (nasal sprays, ODTs) for patients averse to injectables and emphasizes clinical safeguards including third-party lab testing for potency, sterility, pH, and endotoxicity on compounded preparations.
ReadyRx generates revenue through monthly subscription plans priced between $95 (Metformin 90-day program) and $190 per month (NAD+ nasal spray higher tiers), with payment accepted via HSA, FSA, major credit/debit cards, and Klarna buy-now-pay-later plans. Customer acquisition is driven primarily by content marketing, SEO-optimized treatment landing pages, an educational blog library, and earned media coverage including Forbes naming ReadyRx the #1 weight loss and #1 longevity provider in 2025 and a 4.8/5 Trust Pilot rating. The platform claims 5,000+ members, 92% self-reported positive outcomes, and is headquartered in Los Angeles with a headcount of 11–50 employees; no external institutional funding rounds have been disclosed.
ReadyRx firmographics
Firmographics- Name
- ReadyRx
- Legal name
- ReadyRx
- Website
- https://readyrx.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ReadyRx is a US-based direct-to-consumer telehealth platform operated by Executive Medical, LLC that delivers subscription compounded prescription therapies for longevity, weight loss, hormone optimization, and metabolic health to individual adult consumers.
- Ownership category
- akta.pro rank
ReadyRx industry classification
Industry- Product category
- Telehealth Compounded Pharmacy Services
- NAICS
- Other Ambulatory Health Care Services (6219)
- akta.pro primary industry
- Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
- akta.pro secondary industries
- Pharmacogenomics (PGx) Decision Support (HLAAANAB), Condition-specific Digital Therapeutics (DTx) (HLACANAA)
Keywords
Where ReadyRx is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Markets served
ReadyRx business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Prescription Compounded Medications Subscription: Monthly subscription plans for compounded NAD+ therapy in nasal spray and injectable formats, ranging from $130-$190 per month depending on the subscription plan. The platform also offers other compounded therapies including sermorelin, GLP-1 medications, glutathione, metformin, and MIC+B12 through similar subscription models.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | NAD+ Nasal Spray subscription plans |
| Subscription | Multi-year contract | Metformin 90-day program |
| Subscription | Monthly | MIC+B12 10mL Vial |
| Subscription | Monthly | NAD+ Nasal 15mL Bottle |
| Subscription | Monthly | NAD+ Injection - 500mg and 1000mg Vials |
| Subscription | Monthly | Sermorelin ODT 1000mcg |
| Subscription | Monthly | Sermorelin Injection 10mg Vial |
| Subscription | Monthly | Glutathione Injection 2000mg Vial |
| Subscription | Monthly | Tirzepatide and Semaglutide GLP-1 medications |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
ReadyRx product offering
Product offeringCore offering
ReadyRx is a direct-to-consumer telehealth platform that connects patients with independent licensed medical providers who prescribe compounded prescription therapies for longevity, weight loss, hormone optimization, energy, and recovery. Treatments include GLP-1 injections (Semaglutide, Tirzepatide, Ozempic, Zepbound), Sermorelin, NAD+, Glutathione, Metformin, and MIC+B12, delivered through monthly subscriptions directly to the customer's door.
Product overview
ReadyRx is a telehealth platform operated by Executive Medical, LLC that delivers personalized prescription therapies for longevity, weight loss, and metabolic health through a three-party structure involving independent licensed clinicians and affiliated compounding pharmacies. The platform offers a portfolio of 12 distinct treatment products across three categories: Metabolic Health (GLP-1 injections including Semaglutide, Tirzepatide, Ozempic®, and Zepbound® for weight management), Hormone Health (Sermorelin in injectable and orally dissolving tablet formats for growth hormone support), and Energy & Recovery (NAD+ injections and nasal spray, Glutathione injections and nasal spray, Metformin for metabolic support, and MIC+B12 for fat metabolism). All treatments are doctor-prescribed with ongoing peer support, lab testing, and home delivery.
Differentiator
Problem solved
Functional benefit
Products and services
- Semaglutide (GLP-1 Injection) A prescription GLP-1 receptor agonist injection that promotes weight loss by decreasing hunger, increasing fullness, and enhancing the body's ability to burn calories through insulin stimulation. Offered to adult patients seeking metabolic and weight management support.
- Tirzepatide A dual GIP/GLP-1 receptor agonist injection that promotes weight loss by decreasing hunger and enhancing calorie burning through insulin stimulation, providing appetite suppression and metabolic boost. Offered to adult patients seeking weight management support.
- Ozempic FDA-approved brand-name semaglutide medication for management of type 2 diabetes symptoms that contributes to healthy weight loss when combined with diet and exercise. Offered to adult patients seeking weight management support.
- Zepbound FDA-approved GLP-1 receptor agonist injection for weight management that promotes weight loss by decreasing hunger and increasing fullness through GLP-1 receptor action. Offered to adult patients seeking weight management support.
- NAD+ Injection A prescription coenzyme injection that supports cellular energy production, DNA repair, and healthy aging by restoring declining NAD+ levels that fuel mitochondrial function. Offered to adults seeking energy, focus, and longevity support.
- NAD+ Nasal Spray A prescription nasal spray delivering NAD+ directly to the brain via the olfactory nerve for fast-acting support of focus, clarity, and cellular vitality, available in a 4,500mg nasal spray format. Offered to adults seeking needle-free energy and longevity support.
- Sermorelin Injection A synthetic peptide injection that mimics growth hormone-releasing hormone (GHRH) to naturally stimulate the pituitary gland's own growth hormone production, supporting muscle recovery, sleep quality, and metabolism. Offered to adults seeking hormone optimization.
- Sermorelin ODT An orally dissolving tablet containing 1000mcg sermorelin that provides needle-free hormone support, stimulating natural growth hormone production for energy, strength, and deep recovery. Offered to adults seeking needle-free hormone optimization.
- Glutathione Injection A prescription antioxidant injection containing 2000mg glutathione that supports liver detoxification, neutralizes free radicals, reduces oxidative stress, and promotes cellular health. Offered to adults seeking antioxidant and detox support.
- Glutathione Nasal Spray A prescription nasal spray providing fast-acting antioxidant support through the nose, helping reduce oxidative stress and inflammation while supporting immune health and mental clarity. Offered to adults seeking needle-free antioxidant support.
- Metformin An oral medication for blood sugar regulation and metabolic support that helps reduce glucose released by the liver, improve insulin sensitivity, and may support healthy aging, weight management, and cognitive function. Offered to adults seeking longevity and metabolic support via a $95 out-of-pocket 90-day program including doctor consultation.
- MIC+B12 A lipotropic injection combining Methionine, Inositol, Choline, and Vitamin B12 (methylcobalamin) that supports fat metabolism, energy production, and liver function, available in 10mL vials. Offered to adults seeking energy and metabolic support.
Quantifiable outcome
- 92% of reporting patients reported a positive change since starting treatment
- +3 more outcomes
Companies that use ReadyRx
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles1 record
ReadyRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
ReadyRx partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Executive Medical, LLCcoreReadyRx is operated by Executive Medical, LLC, which owns and operates the telehealth platform. Executive Medical provides the technology infrastructure and operational framework for connecting users with independent licensed clinicians and affiliated compounding pharmacies.
- FDA-registered U.S.-based Compounding PharmaciescorePartner compounding pharmacies that dispense medications are FDA-registered, U.S.-based, and follow strict regulatory and safety guidelines. These pharmacies compound personalized medications not available through standard pharmaceutical channels.
- Independent Licensed Medical ProviderscoreBoard-certified, licensed clinicians who evaluate patient candidacy for compounded therapies, review medical histories, determine treatment appropriateness, and provide ongoing monitoring and support through the telehealth platform.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
ReadyRx competitors and assessment
Company assessmentDirect peers
- Hims & Hers Health: Large public DTC telehealth platform offering GLP-1 weight loss, hormone therapy, and broader men's/women's health. Directly comparable business model, customer segment (DTC subscription), and treatment categories to ReadyRx.
- Calibrate: Telehealth metabolic health platform combining GLP-1 medications with coaching for sustainable weight loss. Comparable subscription-based prescription-plus-coaching model targeting metabolic health seekers.
- Ro: DTC telehealth platform with a flagship weight loss program (Ro Body) offering GLP-1s plus coaching, and parallel men's health/longevity lines. Closely comparable DTC prescription subscription model targeting similar consumer segments.
- Found: DTC telehealth platform specializing in weight loss via compounded and FDA-approved medications with affiliated coaching. Directly comparable GLP-1 prescription subscription model with similar compounding pharmacy structure.
- Mochi Health: DTC telehealth platform offering GLP-1 weight loss programs with provider-led care. Comparable prescription subscription model with similar compounding pharmacy supply dynamics and patient onboarding flow.
- LifeMD: Telehealth platform offering GLP-1 weight management, hormone replacement, and primary care subscriptions. Overlapping DTC prescription offerings with broader portfolio including men's/women's health.
- Henry Meds: DTC telehealth platform offering compounded GLP-1 weight loss medications via subscription. Closely comparable prescription subscription model with similar compounding pharmacy dependency.
- Marek Health: DTC telehealth platform focused on hormone optimization, TRT, and longevity treatments including peptides. Comparable niche focus on hormone/peptide therapy for the longevity and performance consumer segment.
- Form Health: Physician-led DTC telehealth weight management platform offering FDA-approved and compounded obesity medications. Directly comparable subscription model for the metabolic health seeker segment.
Emerging players
- Sesame: Online healthcare marketplace offering weight loss visits, prescription medications, and primary care on a cash-pay basis. Comparable cash-pay DTC telehealth entry point but broader marketplace model rather than a subscription specialty clinic.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights5 records
Customer concentration
ReadyRx social profiles
Digital presenceReadyRx compliance and trust
Trust signalCompliance3 records
ReadyRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
ReadyRx leadership team
Management profileNumber of profiles
Profiles2 records
ReadyRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ReadyRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ReadyRx
What does ReadyRx do?
ReadyRx is a direct-to-consumer telehealth platform that connects patients with independent licensed medical providers who prescribe compounded prescription therapies for longevity, weight loss, hormone optimization, energy, and recovery. Treatments include GLP-1 injections (Semaglutide, Tirzepatide, Ozempic, Zepbound), Sermorelin, NAD+, Glutathione, Metformin, and MIC+B12, delivered through monthly subscriptions directly to the customer's door.
Is ReadyRx a public or private company?
ReadyRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ReadyRx founded?
ReadyRx was founded in -1. It employs 11 to 50 people.
Where is ReadyRx based?
ReadyRx is headquartered in Los Angeles, United States, in the North America region.
How does ReadyRx make money?
One revenue line is on record: prescription Compounded Medications Subscription.
Who are ReadyRx's main competitors?
Direct peers on record are Hims & Hers Health, Calibrate, Ro, Found, Mochi Health, LifeMD, Henry Meds, Marek Health and Form Health. Sesame is listed as an emerging player.
Does ReadyRx have an API?
No public API is recorded for ReadyRx.
What industry is ReadyRx in?
ReadyRx's product category is Telehealth Compounded Pharmacy Services. Its primary akta.pro industry code is HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs), with a secondary code of HLAAANAB, Pharmacogenomics (PGx) Decision Support. Its NAICS code is 6219.